A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating

CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether it can give rise to secondary cancers.

A Cutting Edge Treatment for Cancer May Cause Rare, Secondary Cancers - RetailWire

CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says - The New York Times

CAR T-Cell Therapy used in Cancer Treatment

UAB Receives Cutting-Edge Robot to Aid in Prostate Cancer Diagnosis, Treatment

Dr. Rao Papineni on LinkedIn: #radonc #nih #nci #niaid #barda #iaee #kumc #papinenilabs #radres…

Tamer Helmy, PhD على LinkedIn: Summary of FDA CDER Warning Letters in May 2023 - II

Medical Advances in Breast Cancer VCU Massey Comprehensive Cancer Center

Fab Your Unborn Foetus

Wafik S. El-Deiry, MD, PhD, FACP on LinkedIn: A Cutting-Edge Cancer Treatment May Cause Cancer. The FDA Is Investigating…

Cancers, Free Full-Text